Success Stories: Our Committed Team and Premium Processing Upgrade Enabled an Indian Lead Researcher to Get EB1A Approval in Just 27 Days
Client’s Testimonial:
“Thank you so much for your excellent services throughout my EB1A_I140 case preparation and immediate responses whenever required. I appreciate each and every one of the Chen immigration team members for your excellent services.”
On August 7th, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for a Lead Researcher in the Field of Biochemistry and Molecular Biology (Approval Notice).
General Field: Biochemistry and Molecular Biology
Position at the Time of Case Filing: Lead Researcher
Country of Origin: India
Approval Notice Date: August 7th, 2023
Processing Time: 27 days (Premium Processing Requested)
Case Summary:
One of the few leading protein kinases experts in biochemistry and molecular biology, our client hired North America Immigration Law Group to expand our help in achieving EB1A approval on his behalf. Initially, we noted that our client must be able to substantiate three of the six requirements listed below in order to establish his status as an individual with outstanding abilities. These standards ought to demonstrate a consistent level of national or worldwide recognition:
- Evidence of applicant’s original scientific, scholarly, artistic, athletic, or business-related contributions in his field of expertise
- Published material about his excellence in either professional or trade publications or other major media
- Authorship in scholarly, professional, or trade media
- Being asked to judge others individually or on a panel for their work
- Membership in a distinguished association or organization whose membership relies on having an extraordinary ability
- Performing a leading role in a distinguished organization
Therefore, we observed that our client’s impressive background, strong record of past achievements, recognition of expertise by journals seeking his services to review manuscripts, and unique knowledge relevant to his current and future work indicate not only that he qualifies as an alien of extraordinary ability but also that his entry will substantially benefit prospectively the United States.
Therefore, we listed the following relevant information in his EB1A (Alien of Extraordinary Ability) petition packet:
his current research focus is on Human Kinases mainly fibroblast growth receptor tyrosine kinase (FGFR) and P38 kinase. This research addresses some of our nation’s and the world’s most pressing issues, including cardiovascular health, cancer treatments, and crop protection.
Also, his work has resulted in 11 peer-reviewed articles and abstracts that have been published in international journals, and it has been cited 187 times by his peers in at least 37 countries. Therefore, this establishes that the scientific community considers him to be preeminent in his areas of scholarly inquiry.
His extensive involvement in peer review activities highlights his expertise and reputation in the field. He is regularly invited to serve as a peer reviewer for prestigious journals, which speaks to his recognized standing in the scientific community. He has completed 5 reviews to date.
Moreover, we added four letters of recommendation obtained from his fellow experts in the field, discussing our client’s victories. One of them stated:
“[Client] undoubtedly stands at the forefront of his field, making invaluable contributions that drive the advancement of molecular biology and biochemistry. His exceptional proficiency in a wide range of molecular biology, biochemical, and biophysical techniques enable him to conduct comprehensive studies that shed light on fundamental mechanisms and facilitate the development of small molecule inhibitors. With his unwavering dedication and significant contributions, he plays a vital role in propelling the field forward, opening new avenues for therapeutic interventions and ultimately shaping the future of molecular biology and biochemistry.”
Through his successful demonstration of his proficiency and creative research approaches, our client has gained the respect and admiration of his colleagues and established himself as a valuable contributor to the field of molecular biology and biochemistry research. It was with great pleasure that we received approval in August 2023, just 27 days after submitting the application, for his premium processing service upgrade. Together, we achieved a great milestone for our client, and we are appreciative of his continued trust in us.
- Biology (Pathology and Immunology, Human Genetics, Genomics, Molecular Biology, Animal, Plant, Microbiology, Genetics, Botany),
- Chemistry (Organic Chemistry, Biochemistry, Biochemical Engineering, Electrochemical Engineering, Physical Chemistry, Macromolecular Engineering, Polymer Chemistry, Chemical Engineering),
- EB1 Green Card

